Literature DB >> 33574628

Biliary involvement in liver metastases: long-term experience with biliary biopsy from a single center.

Riccardo Inchingolo1,2, Massimiliano Nestola1, Thiago Franchi Nunes3, Stavros Spiliopoulos4, Michele Nardella1.   

Abstract

OBJECTIVE: To investigate long-term results of biliary biopsy performed with transluminal forceps in the setting of metastatic biliary involvement.
MATERIALS AND METHODS: Between September 2014 and June 2019, 25 patients-18 males (72%)-with a mean age of 65 ± 15 years, underwent 26 biliary biopsy procedures with a dedicated forceps system. All patients presented with obstructive jaundice that was suspected of being malignant and underwent pre-procedural magnetic resonance cholangiopancreatography. The biopsies were performed during percutaneous placement of an internal-external biliary drainage catheter, under fluoroscopic guidance.
RESULTS: The technical success rate was 96% (corresponding to 25 of the 26 procedures). The histological diagnosis was inflammatory biliary stricture in five cases, pancreatic adenocarcinoma in six, liver metastases from colorectal cancer in eight, and hepatocellular carcinoma in three, the biliary mucosa being categorized as normal in three cases. In one case, the sample was considered insufficient and the procedure was successfully repeated, after which a diagnosis of pancreatic adenocarcinoma was made. Over a follow-up period of 6-48 months, there were five false-negative results: two findings of inflammatory biliary stricture were later identified as liver metastases from breast and gastric cancer, respectively; and all three patients in which the biliary mucosa was categorized as normal were subsequently diagnosed with metastatic hilar lymph nodes. The procedure was found to have a sensitivity of 77%, a specificity of 100%, and an overall accuracy of 80%. The complication rate was 11.5% (mild, transient hemobilia occurring in three cases).
CONCLUSION: Percutaneous transluminal forceps biopsy is a safe, effective, minimally invasive procedure for histological characterization in patients presenting with obstructive jaundice due to a non-primary biliary tumor.

Entities:  

Keywords:  Biliary tract diseases; Biopsy/methods; Fluoroscopy/methods; Liver; Radiology, interventional/methods

Year:  2021        PMID: 33574628      PMCID: PMC7863718          DOI: 10.1590/0100-3984.2020.0004

Source DB:  PubMed          Journal:  Radiol Bras        ISSN: 0100-3984


  20 in total

1.  Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy.

Authors:  Wael E A Saad; Michael J Wallace; Joan C Wojak; Sanjoy Kundu; John F Cardella
Journal:  J Vasc Interv Radiol       Date:  2010-03-21       Impact factor: 3.464

Review 2.  Personalizing therapy for colorectal cancer.

Authors:  Ashley Wong; Brigette B Y Ma
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-08       Impact factor: 11.382

3.  Percutaneous transluminal biopsy of biliary strictures with a bioptome.

Authors:  K Terasaki; G R Wittich; G Lycke; R Walter; K Nowels; D Swanson; D Lucas
Journal:  AJR Am J Roentgenol       Date:  1991-01       Impact factor: 3.959

4.  Percutaneous transluminal forceps biopsy in patients suspected of having malignant biliary obstruction: factors influencing the outcomes of 271 patients.

Authors:  Jung Gu Park; Gyoo-Sik Jung; Jong Hyouk Yun; Byung Chul Yun; Sang Uk Lee; Byung Hoon Han; Ji Ho Ko
Journal:  Eur Radiol       Date:  2017-03-27       Impact factor: 5.315

5.  Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  J W Valle; I Borbath; S A Khan; F Huguet; T Gruenberger; D Arnold
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

6.  Brush and forceps biopsy of biliary ducts via percutaneous transhepatic catheterization.

Authors:  M K Elyaderani; O F Gabriele
Journal:  Radiology       Date:  1980-06       Impact factor: 11.105

7.  A prospective comparison of the evaluation of biliary obstruction using computed tomography and ultrasonography.

Authors:  R L Baron; R J Stanley; J K Lee; R E Koehler; G L Melson; D M Balfe; P J Weyman
Journal:  Radiology       Date:  1982-10       Impact factor: 11.105

8.  Bile duct: analysis of percutaneous transluminal forceps biopsy in 130 patients suspected of having malignant biliary obstruction.

Authors:  Gyoo-Sik Jung; Jin-Do Huh; Sang Uk Lee; Byung Hoon Han; Hee-Kyung Chang; Young Duk Cho
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

9.  Limitations of percutaneous transhepatic cholangioscopy for the diagnosis of the intramural extension of bile duct carcinoma.

Authors:  M Sato; H Inoue; S Ogawa; S Ohashi; I Maetani; Y Igarashi; Y Sakai
Journal:  Endoscopy       Date:  1998-03       Impact factor: 10.093

10.  Percutaneous transhepatic biliary biopsy using gastrofiberscopic biopsy forceps.

Authors:  C S Kim; Y M Han; H Y Song; K C Choi; D G Kim; B H Cho
Journal:  J Korean Med Sci       Date:  1992-12       Impact factor: 2.153

View more
  2 in total

Review 1.  Endobiliary biopsy.

Authors:  Riccardo Inchingolo; Fabrizio Acquafredda; Alessandro Posa; Thiago Franchi Nunes; Stavros Spiliopoulos; Francesco Panzera; Carlos Alberto Praticò
Journal:  World J Gastrointest Endosc       Date:  2022-05-16

Review 2.  Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer.

Authors:  Takeshi Okamoto
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.